9.58
price up icon36.86%   2.58
after-market After Hours: 9.79 0.21 +2.19%
loading
Neonc Technologies Holdings Inc stock is traded at $9.58, with a volume of 109.68K. It is up +36.86% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$7.00
Open:
$7
24h Volume:
109.68K
Relative Volume:
20.68
Market Cap:
$254.03M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-20.17%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
Value
$6.10
$10.44
1-Week Range:
Value
$6.10
$21.00
52-Week Range:
Value
$6.10
$21.00

Neonc Technologies Holdings Inc Stock (NTHI) Company Profile

Name
Name
Neonc Technologies Holdings Inc
Name
Phone
-
Name
Address
-
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
NTHI's Discussions on Twitter

Compare NTHI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NTHI
Neonc Technologies Holdings Inc
9.58 254.03M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 124.29B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 68.39B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 35.99B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.93B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.47B 3.81B -644.79M -669.77M -6.24

Neonc Technologies Holdings Inc Stock (NTHI) Latest News

pulisher
Apr 01, 2025

Neonc Technologies appoints new accounting firm By Investing.com - Investing.com Canada

Apr 01, 2025
pulisher
Apr 01, 2025

Neonc Technologies appoints new accounting firm - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

NeOnc Technologies Partners with CBCC for Clinical Expansion - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

NeOnc Technologies receives RPDD for NEO100 - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings: New IPO gets a Rare Pediatric Disease Designation and a 37.92% Jump in the Market - RagingBull

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation - MarketScreener

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Falls Despite FDA Nod - Baystreet.ca

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Robinhood, Couchbase And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Mar 31, 2025
pulisher
Mar 31, 2025

NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas - Yahoo Finance

Mar 31, 2025
pulisher
Mar 27, 2025

NeOnc Technologies Expands Global Clinical Trial Network with CBCC Global Research to Accelerate Study of Brain Cancer Treatments - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

NeOnc Technologies Expands Global Clinical Trial Network - GlobeNewswire

Mar 27, 2025
pulisher
Mar 26, 2025

NeOnc Technologies Holdings, Inc. Rings the Opening Bell - Nasdaq

Mar 26, 2025
pulisher
Mar 25, 2025

NTHI IPO NewsBiotech NeOnc Technologies' share registration declared effective ahead of Nasdaq direct listing - renaissancecapital.com

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings Announces Effectiveness of - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

NEONC Technologies Holdings, Inc. Appoints Dr. Alan Chiang to its Board of Directors - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings, Inc. Appoints Bader Almonawer to Board of Directors - GlobeNewswire

Mar 25, 2025
pulisher
Mar 25, 2025

NeOnc Technologies Holdings, Inc. Appoints Dr. Steven L. Giannotta to Board of Directors - Nasdaq

Mar 25, 2025
pulisher
Mar 24, 2025

Nasdaq’s opening bell will ring for USC research startup NeOnc - USC Today

Mar 24, 2025
pulisher
Mar 12, 2025

Planet TV Studios Airing “New Frontiers” Episode on NeOnc Technologies Holdings, Inc. – Saturday, March 15, - EIN News

Mar 12, 2025
pulisher
Feb 19, 2025

Expanding horizons: NeOnc Technologies’ bold vision - The Business Journals

Feb 19, 2025
pulisher
Jan 07, 2025

NeOnc Technologies plans to go public through direct listing - AlphaStreet

Jan 07, 2025
pulisher
Jan 06, 2025

NeOnc Technologies has another go at a Nasdaq listing - Pharmaphorum

Jan 06, 2025
pulisher
Jan 03, 2025

Cancer Drug Co. Revives Bid To Go Public Via Direct Listing - Law360

Jan 03, 2025
pulisher
Oct 07, 2024

NeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024 - GlobeNewswire

Oct 07, 2024
pulisher
Sep 08, 2024

A Biotech Going Through the Nose to Treat the Brain Plots Alternative Path to Public Markets - MedCity News

Sep 08, 2024
pulisher
Aug 05, 2024

NeOnc Technologies Begins Enrollment for Phase 2 Clinical Trial of NEO100-02™ for Patients Afflicted with Meningioma, Marking Second Concurrent Phase 2 Study of Leading CNS Cancer Drug Candidate - GlobeNewswire

Aug 05, 2024
pulisher
Jul 25, 2024

NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors - BioSpace

Jul 25, 2024
pulisher
Jul 16, 2024

NeOnc Technologies Receives FDA Approval to Expand - GlobeNewswire

Jul 16, 2024
pulisher
Jun 26, 2024

NeOnc Technologies Completes $18.5 Million Financing, Advances Phase II Clinical Trials for Enhanced Method of Delivering Novel Therapeutics to the Brain Under FDA Fast-Track Status - GlobeNewswire

Jun 26, 2024
pulisher
Dec 18, 2023

NeOnc Technologies Holdings: NTHI IPO, Health CarePhase 2 biotech developing intranasal and oral therapies for brain cancer. - renaissancecapital.com

Dec 18, 2023
pulisher
Jun 27, 2023

NeOnc Technologies Holdings Receives FDA Authorization to - GlobeNewswire

Jun 27, 2023
pulisher
Apr 18, 2023

NeOnc Technologies Appoints Sidra Medicine CEO and Forbes - GlobeNewswire

Apr 18, 2023
pulisher
Apr 04, 2023

NeOnc Technologies CEO, Thomas Chen, MD, Ph.D., Awarded American Health Council’s ‘Best in Medicine’ - GlobeNewswire

Apr 04, 2023

Neonc Technologies Holdings Inc Stock (NTHI) Financials Data

There is no financial data for Neonc Technologies Holdings Inc (NTHI). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Cap:     |  Volume (24h):